Listing ID #7432833
Company Information
Ask for more detail from the seller
Contact SupplierName:
Category: Drug
and Mydayis are trade names for a combination drug called mixed salts containing four salts of . The mixture is composed of equal parts racemic and , which produces a ratio between and levoamphetamine, the two enantiomers of .
AHFS/Drugs: Monograph
aspartate monohydrate: 25% – stimulant; (12.5% levo; 12.5% dextro)
ATC code: N06BA02 (WHO) N06BA01 (WHO)
Bioavailability: Oral: ~90%
Dependence liability: Moderate – high
Other names: Mixed salts; MAS
Routes of administration: By mouth, insufflation, rectal, sublingual
is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used illicitly as an athletic performance enhancer, cognitive enhancer, appetite suppressant, and recreationally as a euphoriant. It is a central nervous system (CNS) stimulant of the phenethylamine class.
GNH India stands as a prominent figure in the global pharmaceutical distribution arena, boasting an extensive inventory of over 203,000 product lines encompassing both original brands and true generics. As an independent entity, GNH prides itself on its professional management and nearly six years of invaluable experience in the pharmaceutical global trade landscape.
Our services span the entirety of the pharmaceutical trade spectrum, including wholesale distribution, tender supplies, orphan drugs, name patient access programs, biologics, bio-similars, and vaccines. Notably, we are trailblazers in the field of comparator drug supplies from India, procuring pharmaceuticals from over 60 countries to meet clinical trial supply demands both domestically and internationally.
At GNH India, our paramount objective is to furnish consumers with pharmaceutical products that guarantee performance, safety, value, and consistency. This unwavering commitment to quality is deeply ingrained in our corporate ethos and serves as a cornerstone of our ongoing growth and prosperity. We adhere rigorously to a comprehensive set of guidelines, known as 'The GNH Way,' throughout the manufacturing and distribution processes of our diverse range of pharmaceutical offerings.
In essence, GNH India epitomizes excellence in pharmaceutical distribution, driven by a steadfast dedication to quality, integrity, and customer satisfaction. With a rich tapestry of experience and a forward-looking approach, we are poised to continue leading the way in delivering top-tier pharmaceutical solutions to markets around the globe.